Regenative Labs Highlights Advancements in Post-Surgical Breast Reduction
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
Regenative Labs announces care advancements using Wharton’s jelly allografts in post-surgical breast reduction.
Researchers have discovered a naturally occurring protein that could lead to new therapies for preventing excessive scarring in patients during wound healing.